Advertisement

Related Videos

Sarah Yim, MD, on Clinical Development of Biosimilars: Lessons for Interventional Pharmacoeconomics

Matthew Seymour, MD: A Clinical Trialist’s Perspective

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

Advertisement

Advertisement




Apr
15
Today In Oncology
Large Language Models May Generate Concise, Coherent Pathology Summaries, Reducing Physician Burden
PSMA PET-CT Scan Reduces Need for Prostate Cancer Biopsies
Surgery Still Safe Beneficial For Many Octogenarian Patients With NSCLC
Prompting Strategies Improve Symptom Monitoring in Childhood Cancer Survivors
NCCN Names New Chief Scientific Officer
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo